Meticulous Research®, a leading global market research company, published a research report titled, ‘Asia-Pacific Plasma Therapy Market, By Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology, Stomatology), End User (Hospitals & Clinics, Research Institutes) - Forecast to 2030’.
According to the latest report by Meticulous Research®, the Asia-Pacific Plasma Therapy Market is poised to reach $214 million by 2030, exhibiting a CAGR of 13.4% from 2023 to 2030. The growth in this market is fueled by increased healthcare expenditure, a rising geriatric population, and a significant number of accidents in the region. Moreover, conferences advocating for Platelet-Rich Plasma (PRP) use and ongoing research activities further contribute to market expansion. However, stringent regulatory frameworks present a major challenge. Despite this, the increasing applications of PRP treatments and advancements in healthcare infrastructure offer growth opportunities.
Key Players:
Key players in the Asia-Pacific plasma therapy market include Arthrex, Inc., DePuy Synthes, Inc., Global Stem Cells Group, Inc., Terumo Corporation, Regen Lab SA, Stryker Corporation, Zimmer Biomet Holdings, Inc., Exactech Inc., Beijing Manson Technology Co., Ltd., Alocuro, Takeda Pharmaceutical Company Limited, Grifols, S.A., Octapharma AG, and CSL Limited.
Future Outlook:
The market is segmented by type, application, end-user, and country. Pure PRP is anticipated to dominate the market in 2023 due to its efficacy as a point-of-care therapy for various conditions. The dermatology & cosmetology segment is expected to witness the highest CAGR, driven by the increasing incidence of skin and hair-related conditions. Hospitals & clinics are likely to hold the largest market share in 2023, primarily utilizing PRP therapy for pain management, regenerative medicine, and cosmetic enhancements.
Geographic Review:
The report covers major countries including China, Japan, India, South Korea, Australia, Singapore, and the Rest of Asia-Pacific. Japan is expected to lead the market in 2023, attributed to the growing awareness of PRP therapy and increasing infertility issues. Physicians use PRP to aid in fertility treatments, contributing to market growth.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5556
Key Questions Answered in the Report:
Which market segments exhibit high growth potential?
What are the historical and forecasted market trends?
What are the major drivers, restraints, challenges, and opportunities?
Who are the key players in the market?
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research